Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01566513 · ClinicalTrials.gov registry record · NA

Effectiveness and Cost Effectiveness of Peer Mentors in Reducing Hospital Use

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
285
Enrollment target

NCT01566513: Completed NA study, sponsored by Yale University.

NCT01566513 is a NA study that has completed, run by Yale University. The registered enrollment target is 285 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01566513, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
285 participants
Enrollment target

Study Summary

The current study, through a randomized controlled design, will evaluate the effectiveness of peer support, as compared to usual care and to an equivalent amount of support offered by peer case managers and non-peer recovery mentors, in reducing hospital days and readmissions and in promoting recovery and community inclusion among adults with mental illnesses with histories of multiple hospitalizations. The current study evaluates the cost-effectiveness of adding peer support to the array of services available to persons with serious mental illnesses who have histories of multiple hospitalizations and will test a theoretical model of the active ingredients of peer support, focusing specifically on the roles of 1) instillation of hope through positive self-disclosure; 2) role modeling of self-care and exploring new ways of using experiential knowledge; and 3) a trusting relationship characterized by acceptance, understanding, and empathy with conditional regard.

Primary Outcome

Via self-report from the participant

Interventions

  • BEHAVIORAL Community Connector
  • BEHAVIORAL Peer Recovery Mentor
  • BEHAVIORAL Peer Case Manager

Trial Details

FieldValue
Enrollment Target 285 participants
Start Date 2011-08
Est. Completion 2013-11
Phase NA
Yale University

1,492 total trials

What the finished NCT01566513 record still lists

NCT01566513 is an interventional study that assigns participants to a tested intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 3 interventions - of which Community Connector is the first listed.

NCT01566513 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01566513 about?

NCT01566513 is a clinical study titled "Effectiveness and Cost Effectiveness of Peer Mentors in Reducing Hospital Use". The current study, through a randomized controlled design, will evaluate the effectiveness of peer support, as compared to usual care and to an equivalent amount of support offered by peer case managers and non-peer recovery mentors, in reducing hospital days and readmissions and in promoting recove...

What is the current status of trial NCT01566513?

This trial is currently completed. It is a NA study. The enrollment target is 285 participants. The study started on 2011-08. Estimated completion is 2013-11.

What interventions are being tested in trial NCT01566513?

The interventions under investigation include: Community Connector (BEHAVIORAL), Peer Recovery Mentor (BEHAVIORAL), Peer Case Manager (BEHAVIORAL).

Who is sponsoring clinical trial NCT01566513?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01566513's enrollment target sits among peer trials

285 377th of 2000 higher than 1,624 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03412877 · 285 participants · Phase 2

    Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

  • NCT04537936 · 285 participants · NA

    Psychotherapy Intervention for Latinos With Adv Cancer

  • NCT04965675 · 285 participants · Phase 3

    A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

  • NCT05320835 · 285 participants · NA

    A Setting Focus Overdose Prevention Intervention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01566513, the US trial registry maintained by the National Library of Medicine. NCT01566513 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.